Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)
5.74
-0.04 (-0.69%)
Apr 29, 2025, 2:45 PM CST
SHE:300318 Revenue
In the year 2024, Beijing Bohui Innovation Biotechnology Group had annual revenue of 851.69M CNY, down -18.53%. Beijing Bohui Innovation Biotechnology Group had revenue of 205.63M in the quarter ending December 31, 2024, a decrease of -14.08%.
Revenue
851.69M
Revenue Growth
-18.53%
P/S Ratio
5.51
Revenue / Employee
434.32K
Employees
1,961
Market Cap
4.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 851.69M | -193.73M | -18.53% |
Dec 31, 2023 | 1.05B | 249.50M | 31.35% |
Jan 1, 2023 | 795.93M | 81.18M | 11.36% |
Jan 1, 2022 | 714.75M | -23.97M | -3.24% |
Dec 31, 2020 | 738.72M | 110.38M | 17.57% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Shanghai United Imaging Healthcare | 10.30B |